NASDAQ
Rafarma Pharmaceuticals, Inc. (RAFA) has a fcf yield of -0.66% as of Monday, August 3, 2026. This represents a 112.14% decrease compared to its 12-month average of 5.48%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.